• Bernard, M., Drenou, B., Pangault, C., Dauriac, C., Fauchet, R., LePrise, P.Y. & Lamy, T. (1999) Spontaneous phenotypic and molecular blood remission in a case of chronic lymphocytic leukaemia. British Journal of Haematology, 107, 213214.
  • Cheson, B.D., Bennett, J.M., Rai, K.R., Grever, M.R., Kay, N.E., Schiffer, C.A., Oken, M.M., Keating, M.J., Boldt, D.H., Kempin, S.J. & Foon, K. (1988) Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the NCI sponsored working group. American Journal of Hematology, 29, 152163.
  • CLL Trialists' Collaborative Group (1999) Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. Journal of the National Cancer Institute, 91, 861868.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 18401847.
  • Greene, M.H., Hoover, R.N. & Fraumeni, Jr, J.F. (1978) Subsequent cancer in patients with chronic lymphocytic leukemia: a possible immunological mechanism. Journal of the National Cancer Institute, 61, 337340.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 18481854.
  • Hjalmar, V., Kimby, E., Matutes, E., Sundström, C., Jacobsson, B., Arvidsson, I. & Hast, R. (1998) Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders. Haematologica, 83, 602609.
  • Juliusson, G. & Merup, M. (1998) Cytogenetics in chronic lymphocytic leukemia. Seminars in Oncology, 25, 1926.
  • Mu, X., Kay, N.E., Gosland, M.P. & Jennings, C.D. (1997) Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells. British Journal of Haematology, 96, 733735.
  • Oscier, D. (1999) Chronic lymphocytic leukaemia. British Journal of Haematology, 105, 13.
  • Schmidt, H.H., Sill, H., Eibl, M., Beham-Schmid, C., Höfler, G., Haas, O.A., Krejs, G.J. & Linkesch, W. (1995) Hodgkins disease developing after spontaneous remission of chronic lymphocytic leukaemia. Annals of Haematology, 71, 247252.
  • Vuillier, F., Claisse, J.F., Vandenvelde, C., Travade, P., Magnac, C., Chevret, S., Desablens, B., Binet, J.L. & Dighiero, G. (1992) Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements. Leukemia and Lymphoma, 7, 195204.